Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Covalent Software Ltd

8 Aug 2016 07:00

RNS Number : 4674G
Ideagen PLC
08 August 2016
 

8 August 2016

 

Ideagen PLC

("Ideagen" "the Company" or "the Group")

 

Acquisition of Covalent Software Ltd

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to announce the acquisition of the entire issued share capital of Covalent Software Limited ("Covalent") for a net cash consideration of £3.6m ("the Acquisition") payable from Ideagen's existing cash reserves.

 

Highlights

 

· Covalent is a profitable and cash generative software company that has developed a leading Governance, Risk and Compliance ("GRC") cloud-based software platform primarily for the Public Sector and Financial Services markets.

 

· Based in Taunton, Covalent currently employs 37 staff and has approximately 200 customers generating approximately £2.2m of revenue annually of which £1.9m is recurring.

 

· The Acquisition is in line with the Group's strategy of acquiring complementary businesses with strong IP and recurring revenues. Covalent has outstanding IP that can be readily integrated with the Group's existing product set to build a broader and more valuable GRC solution.

 

· The Acquisition is expected to be immediately earnings enhancing.

 

· Covalent's unaudited total revenues for the six months to 30 June 2016 were £1.1m which generated EBITDA of £0.16m.

 

· Ideagen will benefit from a saving relating to outgoing Covalent directors of approximately £0.18m per annum. A proportion of this will be realised in the current financial year following a period of handover and integration.

 

· Ideagen has identified approximately £0.1m of further synergies, which the Directors anticipate will be achievable during the 12 month period ending 30 April 2018.

 

 

David Hornsby, CEO of Ideagen, commented; "Covalent will be a valuable addition to the Group and is in line with our strategy of acquiring business that have strong IP and healthy recurring revenues. Covalent has established an extremely compelling value proposition and brings to the Group a complementary cloud solution offering, a talented workforce and long-term customer relationships which further consolidates our position in the NHS, local government and financial services verticals."

 

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Stuart Andrews/James Thompson (Nomad)

Stephen Norcross (Corporate Broking)

Alma PR

020 8004 4218

Hilary Buchanan

Josh Royston

 

 

Consideration

 

Total cash consideration payable at completion is £4.7 m.

 

Covalent has net cash reserves of £1.1m, giving net cash consideration of £3.6m. The net consideration will be met from Ideagen's existing cash reserves (30 April 2016: £6.3m).

 

In the year ended 31 December 2015 Covalent generated revenues of £2.07m and EBITDA excluding capitalisation of development costs of £0.24m.

 

 

Acquisition Rationale

 

The Acquisition is in line with the Group's strategy of acquiring businesses with strong IP and recurring revenues that supply GRC Solutions to regulated sectors. Covalent has outstanding IP that can be readily integrated with the Group's existing product set to build a broader and more valuable GRC solution, which will provide significant cross selling opportunities and a strong platform for future growth. Covalent's solutions are delivered via its cloud-based platform and further enhances Ideagen's cloud development strategy, which the Directors believe is an area of significant growth area for the Group.

 

Covalent has a talented workforce, which will add to the R&D, support and sales functions of Ideagen. Covalent's Finance and Operations Director, Steve Maggs will remain with the enlarged Group and will be appointed to the role of Director of the Covalent Business Unit, reporting directly to Barnaby Kent, COO of Ideagen, on completion of the Acquisition.

 

 

About Covalent

 

Covalent, a Taunton based software company established in 2003, has developed and commercialised a proprietary GRC platform which has gained significant traction in the UK Public Sector.

 

Covalent currently employs 37 staff and has approximately 200 customers across the NHS, Local Government, Housing Association and Financial Services sectors.

 

Covalent has recently released a Cloud Based version of its software following approximately 40 man years of development which has driven strong growth in recurring revenues.

 

Covalent reported unaudited revenue of approximately £2.07m and generated EBITDA excluding capitalisation of development costs of £0.24m for the year ended 31 December 2015. In addition Covalent currently has recurring revenues of approximately £1.9m per annum. Covalent is debt free with current cash balances of approximately £1.1m. As at 31 December 2015 Covalent had gross assets of £2.0m.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQZMGGRRKDGVZM
Date   Source Headline
20th Apr 20221:01 pmGNWForm 8.3 - [Ideagen plc - 19 04 2022] - (HHL)
20th Apr 202212:58 pmGNWForm 8.3 - [Ideagen plc - 19 04 2022] - (CGWL)
20th Apr 202212:54 pmRNSForm 8.3 - Ideagen plc
20th Apr 202212:34 pmRNSForm 8.3 - Ideagen Plc
20th Apr 202212:28 pmRNSForm 8.3 - Ideagen PLC
20th Apr 202211:56 amBUSForm 8.3 - Ideagen Plc
20th Apr 202211:38 amRNSForm 8.5 (EPT/RI)
20th Apr 202211:11 amRNSForm 8 (DD) - Ideagen Plc
20th Apr 202210:52 amGNWForm 8.3 - Ideagen
20th Apr 202210:42 amGNWForm 8.3 - Ideagen Plc
20th Apr 20229:34 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
20th Apr 20229:11 amRNSForm 8.5 (EPT/RI)
19th Apr 20225:44 pmBUSForm 8.3 - Ideagen PLC
19th Apr 20225:28 pmRNSForm 8.3 - Ideagen PLC
19th Apr 20225:19 pmRNSForm 8.3 - Ideagen plc
19th Apr 20221:32 pmRNSForm 8.3 - Ideagen PLC
19th Apr 20227:00 amRNSResponse to Cinven Statement
14th Apr 20225:26 pmRNSPossible Offer for Ideagen PLC
13th Apr 202212:00 pmRNSIssue of shares, Director/PDMR Shareholding & TVR
8th Apr 202212:30 pmRNSExercise of Options and Total Voting Rights
1st Apr 20227:00 amRNSTotal Voting Rights
25th Mar 20226:00 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNSIssue of Equity and TVR
1st Mar 20222:35 pmRNSDirector/PDMR Shareholding
1st Mar 20222:30 pmRNSTotal Voting Rights
11th Feb 20225:45 pmRNSIssue of Shares under SIP and TVR
11th Feb 202211:01 amRNSHolding(s) in Company
9th Feb 20227:01 amRNSAcquisition of MailManager
9th Feb 20227:00 amRNSChange of Adviser
1st Feb 20228:30 amRNSTotal Voting Rights
13th Jan 20227:01 amRNSGrant of awards under the Ideagen LTIP
13th Jan 20227:00 amRNSUnaudited Interim Results
12th Jan 202212:02 pmRNSIssue of Shares Under SIP and Total Voting Rights
4th Jan 20222:45 pmRNSTotal Voting Rights
14th Dec 20214:30 pmRNSIssue of Shares Under SIP and Total Voting Rights
13th Dec 20216:00 pmRNSHolding(s) in Company
9th Dec 20219:05 amRNSSecond Price Monitoring Extn
9th Dec 20219:00 amRNSPrice Monitoring Extension
9th Dec 20217:00 amRNSResult of Placing and PrimaryBid Offer
8th Dec 20214:50 pmRNSRetail Offer by PrimaryBid
8th Dec 20214:49 pmRNSProposed Placing of Ordinary Shares
1st Dec 20214:15 pmRNSTotal Voting Rights
30th Nov 20217:00 amRNSCapital Markets Day
15th Nov 20217:00 amRNSHalf Year Trading Update and Acquisition
12th Nov 20214:46 pmRNSIssue of new shares under the SIP and TVR
9th Nov 20217:00 amRNSAcquisition of CompliSpace
1st Nov 202111:52 amRNSTotal Voting Rights
28th Oct 20215:30 pmRNSResult of AGM
27th Oct 20217:00 amRNSAcquisitions of Audit Analytics and Ai XPRT
22nd Oct 20217:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.